Purpose: Traditional open approaches for matrix-induced chondrogenesis (AMIC®) carry significant morbidity risks. The purpose of this study is to evaluate the effectiveness of the as all-arthroscopic Autologous Matrix-Induced Chondrogenesis (AT-AMIC®) technique in treating osteochondral lesions of the talus (OLT), with a focus on mid-term functional outcomes and complications rates.
Methods: In this retrospective, multicentric case series, we analyzed 64 patients (39 men, 25 women; age range, 18-71 years) with symptomatic OLTs, confirmed by Magnetic Resonance Imaging (MRI), who were treated with the AT-AMIC technique. The intervention included lesion debridement, subchondral bone microfracture, autologous cancellous bone grafting when needed, and the implantation of a porcine collagen bilayer matrix (Chondro-Gide®). Functional outcomes were assessed using the American Orthopaedic Foot and Ankle Society (AOFAS) score, with a mean follow-up of 44 months (range, 31-62 months). Statistical analysis was performed using the Wilcoxon test, with the significance level set at 5% (p < 0.05).
Results: The average size of the OLTs was 112 mm², with the most common location being Raikin zone 4 (54.68%). The average preoperative AOFAS score was 51.58, which significantly improved to 89.64 at the final follow-up (p < 0.0001). Seven patients (11%) experienced treatment failure due to complications such as membrane detachment, membrane hypertrophy, or recurrence of lesions. No significant correlation was found between lesion size or symptom duration and clinical outcomes.
Conclusion: The AT-AMIC® technique is a reproducible method of treatment for OLTs that resulted in a statistically strong clinical improvement in the mid-term. Further comparative studies are needed to confirm its long-term efficacy.
扫码关注我们
求助内容:
应助结果提醒方式:
